查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1494821

到 2030 年植入式生医材料的市场预测：按材料、应用、最终用户和地区进行的全球分析

Implantable Biomaterials Market Forecasts to 2030 - Global Analysis By Material (Natural Biomaterials, Ceramics and Composites), Application (Ophthalmology, Plastic Surgery and Other Applications), End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2024 年全球植入式生医材料市场规模将达到 1,121.6 亿美元，预计到 2030 年将达到 2,553.9 亿美元，在预测期内复合年增长率为 14.7%。

可植入生医材料是设计用于植入体内用于医疗目的的材料，范围从治疗输送系统到组织替代方案。旨在与生物系统相互作用，不会造成伤害或排斥。这些材料可以是合成的或天然的，它们的特性可以根据特定的应用进行定制，例如生物相容性、机械强度和降解率。

据美国国家公共卫生机构疾病管制与预防中心称，美国20 岁以上成年人中，每 20 人就有 1 人患有心血管疾病。

老年人口增加

由于多种因素，老年人口的增加是植入生医材料市场的关键驱动力。首先，随着年龄的增长，我们更有可能需要依赖生物材料的医疗干预措施，例如关节关节重建、人工植牙和心血管植入。其次，老年人经常患有骨质疏鬆症、心血管疾病等与老龄化相关的疾病，需要使用生医材料进行治疗和支持。此外，医疗保健的进步导致预期寿命更长，进一步增加了对可植入生医材料的需求。

基于生物材料的产品的局限性

儘管基于生物材料的产品具有非常先进的植入式医疗设备，但它们并非没有限制。一个重要的限制是患者对这些材料的反应各不相同，这可能导致免疫反应和组织排斥。此外，随着时间的推移，生物材料的劣化会损害设备的完整性和功能，需要频繁更换或修改。开发和製造基于生物材料的植入的相关成本是另一个主要障碍，通常会导致患者支付高昂的费用。

植入生物材料的优惠报销

植入式生医材料的优惠报销正在为植入式生医材料市场创造重大机会。随着医疗保健系统越来越多地承担与这些材料相关的成本，患者正在转向更先进、更耐用的解决方案。这正在推动需求和采用，推动市场成长。优惠的报销也奖励医疗保健提供者提供这些创新解决方案，进一步扩大市场。此外，该领域的研究和开发已经加速，并导致了更有效和通用的生物材料的引入。这些趋势创造了市场扩张的环境，使患者和行业相关人员受益。

患者遭受严重灾难或个人不幸

在植入式生医材料市场中，材料排斥、植入失败和感染疾病等因素可能会为患者带来重大灾难和个人不幸。当人体的免疫系统对植入材料产生负面反应时，就会发生材料排斥，导致併发症和潜在的健康风险。由于机械问题或与周围组织的整合不当，可能会导致植入失败，需要额外的手术或介入。移植期间或移植后的感染疾病对患者的健康状况构成严重威胁，并可能导致全身性併发症。

COVID-19 的影响：

COVID-19 的爆发对植入式生医材料市场产生了重大影响。由于医疗资源的重新分配和安全问题，选择性手术，包括需要植入生物材料的手术，已被推迟或取消。这减少了对此类材料的需求。此外，全球供应链和製造流程的中断也影响了这些生物材料的可用性。然而，随着医疗保健系统的适应和选择性手术的恢復，市场预计将逐渐復苏。此外，对医疗基础设施弹性和生医材料技术创新的更多关注可能会推动市场未来的成长。

金属和金属合金部门预计将在预测期内成为最大的部门

由于多种因素，植入式生医材料市场中的金属和金属合金领域正在经历显着成长。钛及其合金等金属因其优异的生物相容性、耐腐蚀和机械性能而成为关节重建、人工植牙等植入的理想材料。此外，冶金技术的进步促进了性能改进和客製化特性的新型合金的开发，进一步推动了该领域的成长。整形外科和牙科疾病的日益普及以及寻求植入的人口老化也促进了这一领域的扩张。

整形外科领域预计在预测期内复合年增长率最高

近年来，植入式生医材料市场的整形外科领域经历了显着成长。这种增长是由于多种因素造成的。生物材料技术的进步促进了用于整形外科植入的耐用且生物相容性材料的开发，改善了患者的治疗效果并减少了翻修手术的需要。此外，世界人口老化导致关节重建和脊椎手术等整形外科手术的增加，从而推动了对可植入生医材料的需求。此外，患者和医疗保健提供者对这些植入益处的认识不断提高，也推动了市场的扩张。

比最大的地区

近年来，北美植入式生物材料市场经历了显着成长。这种快速增长归因于多种因素，包括医疗技术的进步、医疗保健支出的增加和人口老化。此外，慢性病和肌肉骨骼疾病盛行率的上升也推动了全部区域对可植入生物材料的需求。此外，主要市场参与者的存在和积极的研发活动进一步刺激了市场扩张。监管支援和优惠报销政策也在推动北美市场成长方面发挥着重要作用。

复合年增长率最高的地区：

由于多种因素，亚太地区的植入式生医材料市场正在显着成长。医疗保健支出的增加、慢性病盛行率的增加以及人口老化正在推动对植入式医疗设备的需求。此外，生物材料技术和外科技术的进步正在支持市场扩张。在医疗基础设施改善和医疗旅游业激增的推动下，中国、医疗保健和日本等国家正在引领成长轨迹。此外，有利的政府措施和支持性法律规范正在鼓励该地区的投资并进一步促进成长。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第四章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球植入生医材料市场：依材料分类

  • 天然生医材料
  • 陶瓷製品
  • 金属和金属合金
  • 合成聚合物
  • 复合材料

第六章全球植入式生医材料市场：依应用分类

  • 眼科
  • 整形外科
  • 创伤治疗
  • 心臟病学
  • 牙科
  • 整形外科
  • 其他用途

第七章全球植入生医材料市场：依最终用户分类

  • 专科诊所
  • 医院
  • 门诊手术中心
  • 其他最终用户

第八章全球植入生医材料市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第九章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十章 公司概况

  • 3M
  • Arthrex
  • BASF SE
  • Bayer AG
  • Berkeley Advanced Biomaterials
  • Biomet
  • Cam Bioceramics BV
  • Carpenter Technology Corporation
  • Celanese Corporation
  • CeramTec
  • Collagen Solutions Plc
  • CoorsTek Inc.
  • DuPont
  • Evonik Industries AG
  • Linden Lab
  • Medtronic
  • Royal DSM
  • Stryker Corporation
  • Zimmer Biomet Holdings
Product Code: SMRC26337

According to Stratistics MRC, the Global Implantable Biomaterials Market is accounted for $112.16 billion in 2024 and is expected to reach $255.39 billion by 2030 growing at a CAGR of 14.7% during the forecast period. Implantable biomaterials are substances designed to be placed inside the body for medical purposes, ranging from therapeutic delivery systems to tissue replacement. They are engineered to interact with biological systems without causing harm or rejection. These materials can be synthetic or natural, and their properties are tailored to specific applications, such as biocompatibility, mechanical strength, and degradation rate.

According to the Centers for Disease Control and Prevention, a US-based national public health agency, in the US, 1 in 20 adults age 20 and older have cardiovascular diseases.

Market Dynamics:

Driver:

The increase in the geriatric population

The rise in the geriatric population is a significant driver for the implantable biomaterials market due to several factors. Firstly, as people age, there's a greater likelihood of needing medical interventions such as joint replacements, dental implants, and cardiovascular implants, all of which rely on biomaterials. Secondly, older individuals often experience age-related conditions like osteoporosis or cardiovascular diseases, necessitating the use of biomaterials for treatment or support. Additionally, advancements in healthcare have led to increased life expectancy, further contributing to the demand for implantable biomaterials.

Restraint:

Limitations of biomaterial-based products

While biomaterial-based products have significantly advanced implantable medical devices, they are not without limitations. One key restraint lies in the variability of patient responses to these materials, leading to potential immune reactions or tissue rejection. Moreover, biomaterial degradation over time can compromise the device's integrity and functionality, necessitating frequent replacements or revisions. The cost associated with developing and manufacturing biomaterial-based implants is another significant barrier, often leading to higher prices for patients.

Opportunity:

Favorable reimbursements for implantable biomaterials

Favorable reimbursements for implantable biomaterials present a significant opportunity in the implantable biomaterials market. With healthcare systems increasingly covering the costs associated with these materials, patients are more inclined towards advanced and durable solutions. This drives demand and adoption, boosting market growth. Favorable reimbursements also incentivize healthcare providers to offer these innovative solutions, further expanding the market. Moreover, it encourages research and development in the field, leading to the introduction of more effective and versatile biomaterials. This trend creates a conducive environment for market expansion, benefiting both patients and industry stakeholders.

Threat:

Huge disasters or personal misfortunes for the patient

In the implantable biomaterials market, huge disasters or personal misfortunes for patients could arise from factors such as material rejection, implant failure, or infection. Material rejection occurs when the body's immune system reacts negatively to the implanted material, leading to complications and potential health risks. Implant failure can result from mechanical issues or improper integration with surrounding tissues, necessitating additional surgeries or interventions. Infections, either during or after implantation can pose serious threats to the patients' health condition and can lead to systemic complications.

Covid-19 Impact:

The COVID-19 pandemic has significantly impacted the implantable biomaterials market. Elective surgeries, including those requiring implantable biomaterials, were postponed or cancelled due to healthcare resource reallocation and safety concerns. This led to a decline in demand for such materials. Additionally, disruptions in the global supply chain and manufacturing processes affected the availability of these biomaterials. However, as healthcare systems adapt and elective procedures resume, the market is expected to gradually recover. Furthermore, increased emphasis on healthcare infrastructure resilience and innovation in biomaterial technologies may drive future growth in the market.

The metals and metal alloys segment is expected to be the largest during the forecast period

The metals and metal alloys segment in the implantable biomaterials market has experienced significant growth due to several factors. Metals like titanium and its alloys are favored for their excellent biocompatibility, corrosion resistance, and mechanical properties, making them ideal for implants such as joint replacements and dental implants. Additionally, advancements in metallurgy have led to the development of new alloys with improved performance and tailored properties, further driving the segment's growth. The increasing prevalence of orthopedic and dental disorders, coupled with an aging population seeking implants, has also contributed to the expansion of this segment.

The Orthopaedics segment is expected to have the highest CAGR during the forecast period

The orthopaedics segment within the implantable biomaterials market has experienced significant growth in recent years. This growth can be attributed to several factors. Advancements in biomaterial technology have led to the development of more durable and biocompatible materials suitable for orthopaedic implants, enhancing patient outcomes and reducing the need for revision surgeries. Additionally, an aging population worldwide has contributed to the rise in orthopaedic procedures, such as joint replacements and spinal surgeries, driving demand for implantable biomaterials. Moreover, increasing awareness among patients and healthcare providers about the benefits of these implants has fueled market expansion.

Region with largest share:

In recent years, North America has experienced notable growth in the implantable biomaterials market. This surge can be attributed to several factors, including advancements in medical technology, increased healthcare expenditure, and a growing aging population. Additionally, the rising prevalence of chronic diseases and musculoskeletal disorders has fuelled the demand for implantable biomaterials across the region. Moreover, the presence of key market players and robust research and development activities has further stimulated market expansion. Regulatory support and favourable reimbursement policies have also played a significant role in fostering market growth in North America.

Region with highest CAGR:

The Asia-Pacific region has witnessed significant growth in the implantable biomaterials market due to several factors. Rising healthcare expenditures, an increasing prevalence of chronic diseases, and a growing aging population are driving the demand for implantable medical devices. Moreover, advancements in biomaterial technology and surgical techniques have bolstered market expansion. Countries like China, India, and Japan are leading the growth trajectory, propelled by improving healthcare infrastructure and a surge in medical tourism. Additionally, favorable government initiatives and supportive regulatory frameworks have encouraged market players to invest in the region, further fueling growth.

Key players in the market

Some of the key players in Implantable Biomaterials market include 3M, Arthrex, BASF SE, Bayer AG, Berkeley Advanced Biomaterials, Biomet, Cam Bioceramics B.V., Carpenter Technology Corporation, Celanese Corporation, CeramTec, Collagen Solutions Plc, CoorsTek Inc., DuPont, Evonik Industries AG, Linden Lab, Medtronic, Royal DSM, Stryker Corporation and Zimmer Biomet Holdings.

Key Developments:

In May 2024, Zimmer Biomet Holdings, Inc., a global medical technology leader, announced the successful completion of the world's first robotic-assisted shoulder replacement surgery using its ROSA Shoulder System. The surgery was performed at Mayo Clinic by John W. Sperling, MD, MBA, Professor of Orthopedic Surgery at Mayo Clinic in Rochester, Minnesota, and a key contributor to the ROSA Shoulder development team.

In May 2024, Arecor and Medtronic say they partnered to create a new type of insulin that would allow for the use of new insulin pump designs. These new insulin pumps in mind would sit under the skin, rather than on the surface of the skin. The research collaboration aims to develop a novel, high-concentration, thermostable insulin for use by Medtronic in a next-generation pump. A new insulin of this kind could minimize the need for pump maintenance interventions and expand utility for physicians while saving costs.

Materials Covered:

  • Natural Biomaterials
  • Ceramics
  • Metals and Metal Alloys
  • Synthetic Polymers
  • Composites

Applications Covered:

  • Ophthalmology
  • Plastic Surgery
  • Wound Healing
  • Cardiology
  • Dental
  • Orthopedics
  • Other Applications

End Users Covered:

  • Specialty Clinics
  • Hospitals
  • Ambulatory Surgical Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Implantable Biomaterials Market, By Material

  • 5.1 Introduction
  • 5.2 Natural Biomaterials
  • 5.3 Ceramics
  • 5.4 Metals and Metal Alloys
  • 5.5 Synthetic Polymers
  • 5.6 Composites

6 Global Implantable Biomaterials Market, By Application

  • 6.1 Introduction
  • 6.2 Ophthalmology
  • 6.3 Plastic Surgery
  • 6.4 Wound Healing
  • 6.5 Cardiology
  • 6.6 Dental
  • 6.7 Orthopedics
  • 6.8 Other Applications

7 Global Implantable Biomaterials Market, By End User

  • 7.1 Introduction
  • 7.2 Specialty Clinics
  • 7.3 Hospitals
  • 7.4 Ambulatory Surgical Centers
  • 7.5 Other End Users

8 Global Implantable Biomaterials Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 3M
  • 10.2 Arthrex
  • 10.3 BASF SE
  • 10.4 Bayer AG
  • 10.5 Berkeley Advanced Biomaterials
  • 10.6 Biomet
  • 10.7 Cam Bioceramics B.V.
  • 10.8 Carpenter Technology Corporation
  • 10.9 Celanese Corporation
  • 10.10 CeramTec
  • 10.11 Collagen Solutions Plc
  • 10.12 CoorsTek Inc.
  • 10.13 DuPont
  • 10.14 Evonik Industries AG
  • 10.15 Linden Lab
  • 10.16 Medtronic
  • 10.17 Royal DSM
  • 10.18 Stryker Corporation
  • 10.19 Zimmer Biomet Holdings

List of Tables

  • Table 1 Global Implantable Biomaterials Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Implantable Biomaterials Market Outlook, By Material (2022-2030) ($MN)
  • Table 3 Global Implantable Biomaterials Market Outlook, By Natural Biomaterials (2022-2030) ($MN)
  • Table 4 Global Implantable Biomaterials Market Outlook, By Ceramics (2022-2030) ($MN)
  • Table 5 Global Implantable Biomaterials Market Outlook, By Metals and Metal Alloys (2022-2030) ($MN)
  • Table 6 Global Implantable Biomaterials Market Outlook, By Synthetic Polymers (2022-2030) ($MN)
  • Table 7 Global Implantable Biomaterials Market Outlook, By Composites (2022-2030) ($MN)
  • Table 8 Global Implantable Biomaterials Market Outlook, By Application (2022-2030) ($MN)
  • Table 9 Global Implantable Biomaterials Market Outlook, By Ophthalmology (2022-2030) ($MN)
  • Table 10 Global Implantable Biomaterials Market Outlook, By Plastic Surgery (2022-2030) ($MN)
  • Table 11 Global Implantable Biomaterials Market Outlook, By Wound Healing (2022-2030) ($MN)
  • Table 12 Global Implantable Biomaterials Market Outlook, By Cardiology (2022-2030) ($MN)
  • Table 13 Global Implantable Biomaterials Market Outlook, By Dental (2022-2030) ($MN)
  • Table 14 Global Implantable Biomaterials Market Outlook, By Orthopedics (2022-2030) ($MN)
  • Table 15 Global Implantable Biomaterials Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 16 Global Implantable Biomaterials Market Outlook, By End User (2022-2030) ($MN)
  • Table 17 Global Implantable Biomaterials Market Outlook, By Specialty Clinics (2022-2030) ($MN)
  • Table 18 Global Implantable Biomaterials Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 19 Global Implantable Biomaterials Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
  • Table 20 Global Implantable Biomaterials Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 21 North America Implantable Biomaterials Market Outlook, By Country (2022-2030) ($MN)
  • Table 22 North America Implantable Biomaterials Market Outlook, By Material (2022-2030) ($MN)
  • Table 23 North America Implantable Biomaterials Market Outlook, By Natural Biomaterials (2022-2030) ($MN)
  • Table 24 North America Implantable Biomaterials Market Outlook, By Ceramics (2022-2030) ($MN)
  • Table 25 North America Implantable Biomaterials Market Outlook, By Metals and Metal Alloys (2022-2030) ($MN)
  • Table 26 North America Implantable Biomaterials Market Outlook, By Synthetic Polymers (2022-2030) ($MN)
  • Table 27 North America Implantable Biomaterials Market Outlook, By Composites (2022-2030) ($MN)
  • Table 28 North America Implantable Biomaterials Market Outlook, By Application (2022-2030) ($MN)
  • Table 29 North America Implantable Biomaterials Market Outlook, By Ophthalmology (2022-2030) ($MN)
  • Table 30 North America Implantable Biomaterials Market Outlook, By Plastic Surgery (2022-2030) ($MN)
  • Table 31 North America Implantable Biomaterials Market Outlook, By Wound Healing (2022-2030) ($MN)
  • Table 32 North America Implantable Biomaterials Market Outlook, By Cardiology (2022-2030) ($MN)
  • Table 33 North America Implantable Biomaterials Market Outlook, By Dental (2022-2030) ($MN)
  • Table 34 North America Implantable Biomaterials Market Outlook, By Orthopedics (2022-2030) ($MN)
  • Table 35 North America Implantable Biomaterials Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 36 North America Implantable Biomaterials Market Outlook, By End User (2022-2030) ($MN)
  • Table 37 North America Implantable Biomaterials Market Outlook, By Specialty Clinics (2022-2030) ($MN)
  • Table 38 North America Implantable Biomaterials Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 39 North America Implantable Biomaterials Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
  • Table 40 North America Implantable Biomaterials Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 41 Europe Implantable Biomaterials Market Outlook, By Country (2022-2030) ($MN)
  • Table 42 Europe Implantable Biomaterials Market Outlook, By Material (2022-2030) ($MN)
  • Table 43 Europe Implantable Biomaterials Market Outlook, By Natural Biomaterials (2022-2030) ($MN)
  • Table 44 Europe Implantable Biomaterials Market Outlook, By Ceramics (2022-2030) ($MN)
  • Table 45 Europe Implantable Biomaterials Market Outlook, By Metals and Metal Alloys (2022-2030) ($MN)
  • Table 46 Europe Implantable Biomaterials Market Outlook, By Synthetic Polymers (2022-2030) ($MN)
  • Table 47 Europe Implantable Biomaterials Market Outlook, By Composites (2022-2030) ($MN)
  • Table 48 Europe Implantable Biomaterials Market Outlook, By Application (2022-2030) ($MN)
  • Table 49 Europe Implantable Biomaterials Market Outlook, By Ophthalmology (2022-2030) ($MN)
  • Table 50 Europe Implantable Biomaterials Market Outlook, By Plastic Surgery (2022-2030) ($MN)
  • Table 51 Europe Implantable Biomaterials Market Outlook, By Wound Healing (2022-2030) ($MN)
  • Table 52 Europe Implantable Biomaterials Market Outlook, By Cardiology (2022-2030) ($MN)
  • Table 53 Europe Implantable Biomaterials Market Outlook, By Dental (2022-2030) ($MN)
  • Table 54 Europe Implantable Biomaterials Market Outlook, By Orthopedics (2022-2030) ($MN)
  • Table 55 Europe Implantable Biomaterials Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 56 Europe Implantable Biomaterials Market Outlook, By End User (2022-2030) ($MN)
  • Table 57 Europe Implantable Biomaterials Market Outlook, By Specialty Clinics (2022-2030) ($MN)
  • Table 58 Europe Implantable Biomaterials Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 59 Europe Implantable Biomaterials Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
  • Table 60 Europe Implantable Biomaterials Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 61 Asia Pacific Implantable Biomaterials Market Outlook, By Country (2022-2030) ($MN)
  • Table 62 Asia Pacific Implantable Biomaterials Market Outlook, By Material (2022-2030) ($MN)
  • Table 63 Asia Pacific Implantable Biomaterials Market Outlook, By Natural Biomaterials (2022-2030) ($MN)
  • Table 64 Asia Pacific Implantable Biomaterials Market Outlook, By Ceramics (2022-2030) ($MN)
  • Table 65 Asia Pacific Implantable Biomaterials Market Outlook, By Metals and Metal Alloys (2022-2030) ($MN)
  • Table 66 Asia Pacific Implantable Biomaterials Market Outlook, By Synthetic Polymers (2022-2030) ($MN)
  • Table 67 Asia Pacific Implantable Biomaterials Market Outlook, By Composites (2022-2030) ($MN)
  • Table 68 Asia Pacific Implantable Biomaterials Market Outlook, By Application (2022-2030) ($MN)
  • Table 69 Asia Pacific Implantable Biomaterials Market Outlook, By Ophthalmology (2022-2030) ($MN)
  • Table 70 Asia Pacific Implantable Biomaterials Market Outlook, By Plastic Surgery (2022-2030) ($MN)
  • Table 71 Asia Pacific Implantable Biomaterials Market Outlook, By Wound Healing (2022-2030) ($MN)
  • Table 72 Asia Pacific Implantable Biomaterials Market Outlook, By Cardiology (2022-2030) ($MN)
  • Table 73 Asia Pacific Implantable Biomaterials Market Outlook, By Dental (2022-2030) ($MN)
  • Table 74 Asia Pacific Implantable Biomaterials Market Outlook, By Orthopedics (2022-2030) ($MN)
  • Table 75 Asia Pacific Implantable Biomaterials Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 76 Asia Pacific Implantable Biomaterials Market Outlook, By End User (2022-2030) ($MN)
  • Table 77 Asia Pacific Implantable Biomaterials Market Outlook, By Specialty Clinics (2022-2030) ($MN)
  • Table 78 Asia Pacific Implantable Biomaterials Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 79 Asia Pacific Implantable Biomaterials Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
  • Table 80 Asia Pacific Implantable Biomaterials Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 81 South America Implantable Biomaterials Market Outlook, By Country (2022-2030) ($MN)
  • Table 82 South America Implantable Biomaterials Market Outlook, By Material (2022-2030) ($MN)
  • Table 83 South America Implantable Biomaterials Market Outlook, By Natural Biomaterials (2022-2030) ($MN)
  • Table 84 South America Implantable Biomaterials Market Outlook, By Ceramics (2022-2030) ($MN)
  • Table 85 South America Implantable Biomaterials Market Outlook, By Metals and Metal Alloys (2022-2030) ($MN)
  • Table 86 South America Implantable Biomaterials Market Outlook, By Synthetic Polymers (2022-2030) ($MN)
  • Table 87 South America Implantable Biomaterials Market Outlook, By Composites (2022-2030) ($MN)
  • Table 88 South America Implantable Biomaterials Market Outlook, By Application (2022-2030) ($MN)
  • Table 89 South America Implantable Biomaterials Market Outlook, By Ophthalmology (2022-2030) ($MN)
  • Table 90 South America Implantable Biomaterials Market Outlook, By Plastic Surgery (2022-2030) ($MN)
  • Table 91 South America Implantable Biomaterials Market Outlook, By Wound Healing (2022-2030) ($MN)
  • Table 92 South America Implantable Biomaterials Market Outlook, By Cardiology (2022-2030) ($MN)
  • Table 93 South America Implantable Biomaterials Market Outlook, By Dental (2022-2030) ($MN)
  • Table 94 South America Implantable Biomaterials Market Outlook, By Orthopedics (2022-2030) ($MN)
  • Table 95 South America Implantable Biomaterials Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 96 South America Implantable Biomaterials Market Outlook, By End User (2022-2030) ($MN)
  • Table 97 South America Implantable Biomaterials Market Outlook, By Specialty Clinics (2022-2030) ($MN)
  • Table 98 South America Implantable Biomaterials Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 99 South America Implantable Biomaterials Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
  • Table 100 South America Implantable Biomaterials Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 101 Middle East & Africa Implantable Biomaterials Market Outlook, By Country (2022-2030) ($MN)
  • Table 102 Middle East & Africa Implantable Biomaterials Market Outlook, By Material (2022-2030) ($MN)
  • Table 103 Middle East & Africa Implantable Biomaterials Market Outlook, By Natural Biomaterials (2022-2030) ($MN)
  • Table 104 Middle East & Africa Implantable Biomaterials Market Outlook, By Ceramics (2022-2030) ($MN)
  • Table 105 Middle East & Africa Implantable Biomaterials Market Outlook, By Metals and Metal Alloys (2022-2030) ($MN)
  • Table 106 Middle East & Africa Implantable Biomaterials Market Outlook, By Synthetic Polymers (2022-2030) ($MN)
  • Table 107 Middle East & Africa Implantable Biomaterials Market Outlook, By Composites (2022-2030) ($MN)
  • Table 108 Middle East & Africa Implantable Biomaterials Market Outlook, By Application (2022-2030) ($MN)
  • Table 109 Middle East & Africa Implantable Biomaterials Market Outlook, By Ophthalmology (2022-2030) ($MN)
  • Table 110 Middle East & Africa Implantable Biomaterials Market Outlook, By Plastic Surgery (2022-2030) ($MN)
  • Table 111 Middle East & Africa Implantable Biomaterials Market Outlook, By Wound Healing (2022-2030) ($MN)
  • Table 112 Middle East & Africa Implantable Biomaterials Market Outlook, By Cardiology (2022-2030) ($MN)
  • Table 113 Middle East & Africa Implantable Biomaterials Market Outlook, By Dental (2022-2030) ($MN)
  • Table 114 Middle East & Africa Implantable Biomaterials Market Outlook, By Orthopedics (2022-2030) ($MN)
  • Table 115 Middle East & Africa Implantable Biomaterials Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 116 Middle East & Africa Implantable Biomaterials Market Outlook, By End User (2022-2030) ($MN)
  • Table 117 Middle East & Africa Implantable Biomaterials Market Outlook, By Specialty Clinics (2022-2030) ($MN)
  • Table 118 Middle East & Africa Implantable Biomaterials Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 119 Middle East & Africa Implantable Biomaterials Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
  • Table 120 Middle East & Africa Implantable Biomaterials Market Outlook, By Other End Users (2022-2030) ($MN)